DK424989D0 - Rekombinant, naturlig, draebercelleaktiverende faktor - Google Patents

Rekombinant, naturlig, draebercelleaktiverende faktor

Info

Publication number
DK424989D0
DK424989D0 DK424989A DK424989A DK424989D0 DK 424989 D0 DK424989 D0 DK 424989D0 DK 424989 A DK424989 A DK 424989A DK 424989 A DK424989 A DK 424989A DK 424989 D0 DK424989 D0 DK 424989D0
Authority
DK
Denmark
Prior art keywords
activating factor
cell activating
recombinant
natural killer
killer cell
Prior art date
Application number
DK424989A
Other languages
English (en)
Other versions
DK424989A (da
Inventor
Kentaro Yoshimatsu
Yukio Ohya
Yasushi Shikata
Isao Tanaka
Yoshikazu Hasegawa
Toshio Seto
Toshiaki Osawa
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of DK424989D0 publication Critical patent/DK424989D0/da
Publication of DK424989A publication Critical patent/DK424989A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Meat, Egg Or Seafood Products (AREA)
DK424989A 1988-08-31 1989-08-29 Rekombinant, naturlig, draebercelleaktiverende faktor DK424989A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21759988 1988-08-31

Publications (2)

Publication Number Publication Date
DK424989D0 true DK424989D0 (da) 1989-08-29
DK424989A DK424989A (da) 1990-03-01

Family

ID=16706821

Family Applications (1)

Application Number Title Priority Date Filing Date
DK424989A DK424989A (da) 1988-08-31 1989-08-29 Rekombinant, naturlig, draebercelleaktiverende faktor

Country Status (10)

Country Link
US (2) US5185431A (da)
EP (1) EP0357067B1 (da)
KR (1) KR900003371A (da)
AT (1) ATE118037T1 (da)
AU (1) AU4009789A (da)
CA (1) CA1335360C (da)
DE (1) DE68920931T2 (da)
DK (1) DK424989A (da)
FI (1) FI893833A7 (da)
NO (1) NO893452L (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457038A (en) * 1988-11-10 1995-10-10 Genetics Institute, Inc. Natural killer stimulatory factor
US5811523A (en) 1988-11-10 1998-09-22 Trinchieri; Giorgio Antibodies to natural killer stimulatory factor
ATE140483T1 (de) * 1988-11-10 1996-08-15 Genetics Inst Natürlicher killerzellen-stimulationsfaktor
US6683046B1 (en) 1989-12-22 2004-01-27 Hoffmann-La Roche Inc. Purification and characterization of cytotoxic lymphocyte maturation factor and monoclonal antibodies thereto
JP3479539B2 (ja) 1992-04-10 2003-12-15 エーザイ株式会社 ヒトアンチトロンビンｉｉｉ変異体
AU2818695A (en) * 1995-06-06 1996-12-24 Human Genome Sciences, Inc. Natural killer cell enhancing factor c
US6255079B1 (en) 1995-06-06 2001-07-03 Human Genome Sciences, Inc. Polynucleotides encoding natural killer cell enhancing factor C
WO1996040947A1 (en) * 1995-06-07 1996-12-19 Washington University Recombinant bacterial system with environmentally limited viability
EP0937147A1 (en) * 1996-04-03 1999-08-25 Human Genome Sciences, Inc. Human natural killer cell activating factor ii
US6448044B2 (en) 1996-04-03 2002-09-10 Human Genome Sciences, Inc. DNA encoding human natural killer cell activating factor II
US7026456B1 (en) 1998-01-23 2006-04-11 Hoffman-La Roche, Inc. Antibodies against human IL-12
EP1930438A1 (en) * 2006-12-07 2008-06-11 Academisch Medisch Centrum bij de Universiteit van Amsterdam Transcription factor for killer cell activation, differentiation and uses thereof
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN114736268B (zh) * 2022-03-01 2024-09-27 吉林农业大学 一种提高活性肽ace抑制率的修饰方法、ace抑制肽及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
JPS6197224A (ja) * 1984-10-19 1986-05-15 Eisai Co Ltd 新規なリンホカイン

Also Published As

Publication number Publication date
CA1335360C (en) 1995-04-25
US5316933A (en) 1994-05-31
NO893452L (no) 1990-03-01
EP0357067A2 (en) 1990-03-07
DE68920931T2 (de) 1995-07-06
DE68920931D1 (de) 1995-03-16
US5185431A (en) 1993-02-09
EP0357067A3 (en) 1991-08-21
FI893833A0 (fi) 1989-08-15
DK424989A (da) 1990-03-01
FI893833A7 (fi) 1990-03-01
EP0357067B1 (en) 1995-02-01
AU4009789A (en) 1990-03-08
KR900003371A (ko) 1990-03-26
NO893452D0 (no) 1989-08-29
ATE118037T1 (de) 1995-02-15

Similar Documents

Publication Publication Date Title
DK424989A (da) Rekombinant, naturlig, draebercelleaktiverende faktor
KR850004273A (ko) 안정성이 증대된 재조합 감마 인터페론 및 그의 제조방법
AU6819294A (en) Oral drug delivery compositions and methods
ATE173478T1 (de) Varianten des pankreatischen rinder- trypsininhibitors, deren herstellung und verwendung
ATE493998T1 (de) Pharmazeutische zusammensetzung mit einem exendin-4-peptid
IS5087A (is) Stöðugar interferónlyfjablöndur á vökvaformi
TW343198B (en) Cyclopeptides useful as adhesion inhibitors, process for the preparation thereof, and pharmaceutical composition containing them
ATE22449T1 (de) Dynorphinamidanaloge.
CA2094027A1 (en) Osteogenic peptides
ATE121755T1 (de) Deletionsanaloga von magaininpeptiden.
ES2012720A6 (es) Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada.
AU1431188A (en) Dihydropyridine - pyridinium salt-type redox amino acids and peptides containing them
MY103251A (en) Biologically active molecules
IL88378A (en) Human interferon-gamma binding proteins their manufacture and pharmaceutical compositions comprising them
CA2139571A1 (en) Interferon receptor binding peptides
ATE30919T1 (de) Magensekretion hemmende peptidderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
DE3650035D1 (de) THF-Zusammensetzungen.
ATE45165T1 (de) Reduzierte peptide, hemmungsstoffe gastrischer ausscheidung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
MY104088A (en) Peptide-drugs compositions containing (alpha)-aminoboroic acid derivatives.
AR018532A1 (es) Proteinas sustancialmente puras que contienen analogos de la beta-lipoproteina (blt); aislados de acidos nucleicos que codifican dichas proteinas yformulaciones farmaceuticas que comprenden las proteinas
ATE46173T1 (de) Pharmakologisch aktive peptide.
ES8204713A1 (es) Un procedimiento para aislar un polipeptido purificado
CA2247998A1 (en) Fragments of cr1 and their use
KR840007567A (ko) 펩티드의 제조방법
ATE87939T1 (de) Glycosylierte aminosaeuren und peptide.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment